BRILINTA FDA approval : AstraZeneca has bagged approval for BRILINTA (ticagrelor) from the US Food and Drug Administration for its use in reducing the risk of stroke in patients having acute ischemic stroke or high-risk transient ischemic attack (TIA). The FDA approval was driven by the positive results from the THALES phase 3 clinical trial […]
Wayne Pharmaceuticals has launched Dr Wayne’s Aspirin Tablets in the US in a bottle package containing 300 tablets, each having 81mg strength. Dr. Wayne’s Aspirin is an enteric-coated tablet which does not upset the stomach. Aspirin tablets are mainly used to lower the stroke risk in persons who had a mini-stroke (transient ischemic attack) or […]
A seven-year study has found that daily aspirin intake does not lower the risk of heart attack or stroke in older adults, nor does it extend a life free of disability. Conducted with more than 19,000 participants from the US and Australia, the research challenges long-standing assumptions about the benefits of aspirin. Key Findings from […]